Document Details

Form
3
Filing Date
Mar 18, 2026
Document Date
Mar 18, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
BioLineRx
Issuer
BioLineRx Ltd.
Filer
ZEEVI MALI

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients

Discover our Pipeline